Telefon AB L.M. Ericsson Series A (0O86)
London Exchange · UK · prices in SEK · close of 22 Oct 2026
Key indicators
| Last close | SEK 105.00 |
|---|---|
| 52-week range | 84.80 – 128.20 |
| Return, 1 month / 3 months | +10.3% / +14.6% |
| Return, 1 year / 3 years | +21.4% / +128.1% |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 34.2% |
| Worst drawdown (1 year) | -26.9% |
| Average daily value traded | 0.14M SEK |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ericsson is a Swedish supplier of telecommunications equipment and related services. The company builds mobile network infrastructure, including radio access equipment and core network systems, and provides software for managing and operating those networks. Its customers are mainly telecom operators and other network providers around the world, and it also offers support and managed services. Ericsson is based in Sweden and operates internationally, serving both mobile and fixed network markets.
Telefon AB L.M. Ericsson Series A trades under the code 0O86 on the London Exchange in UK, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Telefon AB L.M. Ericsson Series A (0O86) trades on the London Exchange in UK. It last closed at SEK 105.00 on 22 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 1,982 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 21.4% and over the last three months it rose 14.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.0% | ||
| From 52-week high | -17.6% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 14.6% | ||
| 6-month return | -0.7% | ||
| 12-month return, skipping the last month | 10.0% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.9% | ||
| Liquidity | 33 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.14M SEK | ||
| Zero-volume days | 1.7% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.6% |
|---|---|
| 1 month | +10.3% |
| 3 months | +14.6% |
| 6 months | −0.7% |
| 1 year | +21.4% |
| 3 years | +128.1% |
| 5 years | +26.7% |
Signals
| 50-day / 200-day average | 97.02 / 99.99 |
|---|---|
| Golden / death cross (60 days) | Death, 28 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.95 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Sep 2026 | SEK 1.5000 |
| 1 Apr 2026 | SEK 1.5000 |
| 26 Sep 2025 | SEK 1.4200 |
| 26 Mar 2025 | SEK 1.4300 |
| 1 Oct 2024 | SEK 1.3500 |
| 4 Apr 2024 | SEK 1.3500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.